| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Angiography | 109 | 2024 | 4576 | 7.750 |
Why?
|
| Coronary Stenosis | 36 | 2022 | 833 | 6.880 |
Why?
|
| Plaque, Atherosclerotic | 36 | 2024 | 1518 | 5.990 |
Why?
|
| Coronary Artery Disease | 89 | 2024 | 6485 | 5.470 |
Why?
|
| Chest Pain | 40 | 2024 | 1114 | 4.480 |
Why?
|
| Acute Coronary Syndrome | 38 | 2024 | 2337 | 4.340 |
Why?
|
| Coronary Vessels | 39 | 2024 | 3106 | 3.780 |
Why?
|
| Tomography, X-Ray Computed | 83 | 2023 | 20121 | 2.630 |
Why?
|
| Angina Pectoris | 8 | 2021 | 977 | 2.140 |
Why?
|
| Troponin I | 8 | 2022 | 619 | 1.660 |
Why?
|
| Predictive Value of Tests | 60 | 2024 | 15067 | 1.530 |
Why?
|
| Troponin | 8 | 2024 | 524 | 1.250 |
Why?
|
| Fractional Flow Reserve, Myocardial | 4 | 2020 | 289 | 1.210 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 14 | 2017 | 1184 | 0.980 |
Why?
|
| Exercise Test | 8 | 2020 | 2074 | 0.950 |
Why?
|
| Risk Assessment | 42 | 2024 | 23327 | 0.880 |
Why?
|
| Heart Diseases | 9 | 2023 | 2789 | 0.840 |
Why?
|
| Calcinosis | 13 | 2018 | 1495 | 0.780 |
Why?
|
| Calcium | 13 | 2023 | 5755 | 0.760 |
Why?
|
| Tomography, Spiral Computed | 8 | 2008 | 280 | 0.730 |
Why?
|
| Cardiovascular Diseases | 12 | 2023 | 15142 | 0.700 |
Why?
|
| Cardiology | 8 | 2024 | 1668 | 0.700 |
Why?
|
| Myocardial Infarction | 20 | 2023 | 11708 | 0.690 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2022 | 3255 | 0.670 |
Why?
|
| Atherosclerosis | 7 | 2024 | 3445 | 0.630 |
Why?
|
| Prognosis | 33 | 2024 | 29052 | 0.620 |
Why?
|
| Humans | 202 | 2024 | 743811 | 0.550 |
Why?
|
| Risk Factors | 46 | 2023 | 72252 | 0.540 |
Why?
|
| Emergency Service, Hospital | 23 | 2023 | 7658 | 0.530 |
Why?
|
| Radiographic Image Enhancement | 9 | 2014 | 885 | 0.520 |
Why?
|
| Middle Aged | 109 | 2024 | 213241 | 0.520 |
Why?
|
| Constriction, Pathologic | 5 | 2023 | 1108 | 0.510 |
Why?
|
| Primary Prevention | 1 | 2022 | 1167 | 0.500 |
Why?
|
| Coronary Disease | 8 | 2017 | 6078 | 0.500 |
Why?
|
| Arteriosclerosis | 1 | 2018 | 1092 | 0.460 |
Why?
|
| Male | 122 | 2024 | 349776 | 0.450 |
Why?
|
| Myocardial Revascularization | 6 | 2020 | 841 | 0.440 |
Why?
|
| Female | 123 | 2024 | 380020 | 0.440 |
Why?
|
| Severity of Illness Index | 21 | 2020 | 15526 | 0.420 |
Why?
|
| Societies, Medical | 11 | 2023 | 3740 | 0.410 |
Why?
|
| Neoplasms | 4 | 2023 | 21675 | 0.390 |
Why?
|
| Angiocardiography | 1 | 2010 | 162 | 0.380 |
Why?
|
| Cardiovascular System | 3 | 2023 | 828 | 0.360 |
Why?
|
| Observer Variation | 9 | 2018 | 2592 | 0.330 |
Why?
|
| Automation | 4 | 2017 | 584 | 0.330 |
Why?
|
| Ultrasonography, Interventional | 7 | 2018 | 1486 | 0.330 |
Why?
|
| Echocardiography, Stress | 3 | 2021 | 131 | 0.330 |
Why?
|
| Aged | 65 | 2024 | 163178 | 0.320 |
Why?
|
| Sensitivity and Specificity | 27 | 2021 | 14714 | 0.320 |
Why?
|
| Heart Transplantation | 4 | 2013 | 3113 | 0.320 |
Why?
|
| Myocardial Ischemia | 2 | 2018 | 2150 | 0.310 |
Why?
|
| Contrast Media | 15 | 2019 | 5301 | 0.310 |
Why?
|
| Prospective Studies | 37 | 2024 | 53250 | 0.300 |
Why?
|
| Reproducibility of Results | 21 | 2020 | 19894 | 0.300 |
Why?
|
| Iohexol | 2 | 2019 | 196 | 0.290 |
Why?
|
| Diagnostic Imaging | 4 | 2023 | 3503 | 0.290 |
Why?
|
| Leg | 2 | 2023 | 1116 | 0.290 |
Why?
|
| Myocardial Perfusion Imaging | 3 | 2020 | 555 | 0.290 |
Why?
|
| Enterococcus faecium | 3 | 2005 | 99 | 0.290 |
Why?
|
| Heart Function Tests | 3 | 2020 | 328 | 0.280 |
Why?
|
| Heart Ventricles | 6 | 2020 | 3817 | 0.280 |
Why?
|
| Image Processing, Computer-Assisted | 11 | 2017 | 8939 | 0.260 |
Why?
|
| Peripheral Arterial Disease | 3 | 2022 | 1188 | 0.260 |
Why?
|
| Cell Adhesion Molecules | 3 | 2001 | 1602 | 0.260 |
Why?
|
| Triage | 6 | 2016 | 977 | 0.250 |
Why?
|
| Adipose Tissue | 6 | 2023 | 3280 | 0.250 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2023 | 793 | 0.230 |
Why?
|
| Pericardium | 3 | 2020 | 667 | 0.230 |
Why?
|
| Probiotics | 3 | 2005 | 350 | 0.230 |
Why?
|
| Algorithms | 11 | 2020 | 13869 | 0.230 |
Why?
|
| Rupture, Spontaneous | 3 | 2020 | 354 | 0.230 |
Why?
|
| Acute Disease | 9 | 2019 | 7150 | 0.220 |
Why?
|
| Superoxides | 4 | 2001 | 387 | 0.220 |
Why?
|
| United States | 20 | 2023 | 69859 | 0.220 |
Why?
|
| Aortic Valve | 5 | 2023 | 1920 | 0.220 |
Why?
|
| Area Under Curve | 4 | 2015 | 1654 | 0.220 |
Why?
|
| Cardiac-Gated Imaging Techniques | 3 | 2019 | 143 | 0.210 |
Why?
|
| Telecommunications | 1 | 2021 | 80 | 0.200 |
Why?
|
| Electrocardiography | 9 | 2017 | 6441 | 0.190 |
Why?
|
| Periodicals as Topic | 3 | 2022 | 1429 | 0.190 |
Why?
|
| Phantoms, Imaging | 2 | 2006 | 2479 | 0.190 |
Why?
|
| Heart | 5 | 2024 | 4460 | 0.190 |
Why?
|
| Adult | 44 | 2024 | 213889 | 0.190 |
Why?
|
| Journal Impact Factor | 1 | 2022 | 155 | 0.180 |
Why?
|
| Cardiac Volume | 1 | 2021 | 210 | 0.180 |
Why?
|
| Ventricular Function, Left | 3 | 2007 | 3660 | 0.180 |
Why?
|
| Inflammation | 7 | 2024 | 10629 | 0.180 |
Why?
|
| Venous Insufficiency | 1 | 2001 | 103 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2019 | 9944 | 0.170 |
Why?
|
| Microvascular Angina | 1 | 2019 | 15 | 0.170 |
Why?
|
| American Heart Association | 2 | 2022 | 1057 | 0.170 |
Why?
|
| Biomedical Research | 3 | 2021 | 3308 | 0.170 |
Why?
|
| Aorta | 2 | 2005 | 2062 | 0.170 |
Why?
|
| Multivariate Analysis | 7 | 2017 | 12243 | 0.170 |
Why?
|
| ROC Curve | 6 | 2019 | 3527 | 0.170 |
Why?
|
| Echocardiography | 6 | 2019 | 5096 | 0.160 |
Why?
|
| Advisory Committees | 1 | 2022 | 775 | 0.160 |
Why?
|
| Cohort Studies | 14 | 2023 | 40545 | 0.160 |
Why?
|
| Preventive Health Services | 1 | 2022 | 575 | 0.150 |
Why?
|
| Cardiology Service, Hospital | 1 | 2019 | 246 | 0.150 |
Why?
|
| Retrospective Studies | 19 | 2021 | 77410 | 0.150 |
Why?
|
| Tomography, Optical Coherence | 5 | 2024 | 2657 | 0.140 |
Why?
|
| Critical Pathways | 1 | 2021 | 476 | 0.140 |
Why?
|
| Cardiotoxins | 1 | 2016 | 41 | 0.140 |
Why?
|
| Adjuvants, Immunologic | 2 | 2000 | 999 | 0.140 |
Why?
|
| Retroperitoneal Fibrosis | 1 | 2016 | 38 | 0.140 |
Why?
|
| Triiodobenzoic Acids | 5 | 2008 | 124 | 0.130 |
Why?
|
| Neutrophils | 6 | 2001 | 3718 | 0.130 |
Why?
|
| Evidence-Based Medicine | 6 | 2023 | 3608 | 0.130 |
Why?
|
| Odds Ratio | 7 | 2021 | 9848 | 0.130 |
Why?
|
| Hospitalization | 8 | 2021 | 10259 | 0.130 |
Why?
|
| Inflammation Mediators | 2 | 2001 | 1888 | 0.130 |
Why?
|
| Vasculitis | 1 | 2019 | 519 | 0.130 |
Why?
|
| Aortic Diseases | 1 | 2021 | 743 | 0.130 |
Why?
|
| Diffusion of Innovation | 4 | 2021 | 725 | 0.130 |
Why?
|
| Angina, Unstable | 4 | 2021 | 926 | 0.120 |
Why?
|
| North America | 4 | 2019 | 1249 | 0.120 |
Why?
|
| Disease Progression | 8 | 2017 | 13273 | 0.120 |
Why?
|
| Aortic Valve Stenosis | 2 | 2023 | 1955 | 0.120 |
Why?
|
| Photography | 1 | 2017 | 519 | 0.120 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2008 | 314 | 0.120 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2023 | 1187 | 0.120 |
Why?
|
| Feasibility Studies | 4 | 2019 | 5078 | 0.120 |
Why?
|
| Heart Valve Diseases | 2 | 2016 | 1073 | 0.120 |
Why?
|
| Ultrasonography | 5 | 2015 | 5986 | 0.110 |
Why?
|
| Multicenter Studies as Topic | 1 | 2018 | 1676 | 0.110 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 3 | 2015 | 1108 | 0.110 |
Why?
|
| Prevalence | 6 | 2019 | 15211 | 0.110 |
Why?
|
| Aortitis | 1 | 2013 | 74 | 0.110 |
Why?
|
| Emergency Medical Services | 2 | 2018 | 1917 | 0.110 |
Why?
|
| Mammaplasty | 1 | 2022 | 1204 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2022 | 3208 | 0.100 |
Why?
|
| Software | 2 | 2017 | 4440 | 0.100 |
Why?
|
| Radiotherapy | 1 | 2019 | 1533 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2006 | 2281 | 0.100 |
Why?
|
| Health Records, Personal | 1 | 2013 | 124 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 6539 | 0.100 |
Why?
|
| Registries | 2 | 2018 | 8090 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 1738 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 1999 | 2077 | 0.100 |
Why?
|
| Time Factors | 11 | 2020 | 40038 | 0.100 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2007 | 579 | 0.100 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2019 | 941 | 0.090 |
Why?
|
| Ventricular Remodeling | 1 | 2018 | 1225 | 0.090 |
Why?
|
| Outpatients | 1 | 2018 | 1488 | 0.090 |
Why?
|
| Logistic Models | 5 | 2017 | 13404 | 0.090 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1990 | 204 | 0.090 |
Why?
|
| Curriculum | 1 | 2023 | 3603 | 0.090 |
Why?
|
| Dyspnea | 1 | 2017 | 1303 | 0.090 |
Why?
|
| Carotid Stenosis | 1 | 2017 | 854 | 0.090 |
Why?
|
| Women's Health | 1 | 2018 | 2033 | 0.080 |
Why?
|
| Artifacts | 3 | 2007 | 1904 | 0.080 |
Why?
|
| Aorta, Thoracic | 2 | 2013 | 1084 | 0.080 |
Why?
|
| Health Care Costs | 2 | 2019 | 3207 | 0.080 |
Why?
|
| Diagnosis, Differential | 7 | 2019 | 12954 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2019 | 2614 | 0.080 |
Why?
|
| Lipid Metabolism | 2 | 2013 | 1885 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11524 | 0.080 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 12354 | 0.080 |
Why?
|
| Troponin T | 1 | 2013 | 754 | 0.080 |
Why?
|
| Collateral Circulation | 1 | 2008 | 287 | 0.080 |
Why?
|
| Image Enhancement | 2 | 2017 | 2915 | 0.080 |
Why?
|
| Alzheimer Disease | 3 | 2006 | 8035 | 0.080 |
Why?
|
| Comprehension | 1 | 2013 | 610 | 0.070 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2008 | 153 | 0.070 |
Why?
|
| Angiography | 2 | 2023 | 1638 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2023 | 35409 | 0.070 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 6895 | 0.070 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2007 | 141 | 0.070 |
Why?
|
| Documentation | 1 | 2013 | 871 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2017 | 4197 | 0.070 |
Why?
|
| Myocardial Reperfusion | 1 | 2008 | 351 | 0.070 |
Why?
|
| Markov Chains | 2 | 2020 | 968 | 0.070 |
Why?
|
| Drug Prescriptions | 1 | 2015 | 1636 | 0.070 |
Why?
|
| Survivors | 1 | 2016 | 2291 | 0.070 |
Why?
|
| Sex Factors | 5 | 2021 | 10394 | 0.070 |
Why?
|
| Transplantation, Homologous | 2 | 2012 | 4777 | 0.070 |
Why?
|
| Phenotype | 3 | 2022 | 16361 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 4033 | 0.070 |
Why?
|
| Radiopharmaceuticals | 2 | 2013 | 2647 | 0.070 |
Why?
|
| Atrial Fibrillation | 3 | 2011 | 5033 | 0.070 |
Why?
|
| Pulmonary Veins | 1 | 2011 | 761 | 0.060 |
Why?
|
| Catheter Ablation | 2 | 2011 | 2758 | 0.060 |
Why?
|
| Chi-Square Distribution | 4 | 2013 | 3503 | 0.060 |
Why?
|
| Lower Extremity | 2 | 2023 | 1158 | 0.060 |
Why?
|
| Cholesterol | 2 | 2023 | 2922 | 0.060 |
Why?
|
| Follow-Up Studies | 6 | 2023 | 39001 | 0.060 |
Why?
|
| Integrin alpha4 | 1 | 2005 | 92 | 0.060 |
Why?
|
| Arteriovenous Fistula | 1 | 2008 | 315 | 0.060 |
Why?
|
| Incidence | 4 | 2017 | 20948 | 0.060 |
Why?
|
| Electric Countershock | 1 | 2008 | 534 | 0.060 |
Why?
|
| Massachusetts | 1 | 2017 | 8660 | 0.060 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2013 | 2016 | 0.060 |
Why?
|
| Patient Discharge | 3 | 2024 | 3317 | 0.060 |
Why?
|
| Aged, 80 and over | 11 | 2019 | 57744 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2000 | 4437 | 0.060 |
Why?
|
| Heart Atria | 2 | 2011 | 1357 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 3320 | 0.060 |
Why?
|
| Aspirin | 1 | 2015 | 3283 | 0.060 |
Why?
|
| Glucuronidase | 3 | 2001 | 207 | 0.060 |
Why?
|
| Single-Blind Method | 4 | 2009 | 1586 | 0.060 |
Why?
|
| Nonlinear Dynamics | 1 | 2006 | 501 | 0.060 |
Why?
|
| Electronic Health Records | 1 | 2020 | 4467 | 0.060 |
Why?
|
| Muramidase | 2 | 2001 | 174 | 0.060 |
Why?
|
| Comparative Effectiveness Research | 2 | 2019 | 680 | 0.060 |
Why?
|
| Echocardiography, Doppler | 1 | 2007 | 935 | 0.050 |
Why?
|
| Angioplasty, Balloon | 1 | 2007 | 653 | 0.050 |
Why?
|
| Neurofibrillary Tangles | 2 | 2006 | 439 | 0.050 |
Why?
|
| Heart Rate | 4 | 2007 | 4091 | 0.050 |
Why?
|
| Epigastric Arteries | 1 | 2022 | 96 | 0.050 |
Why?
|
| Natural Language Processing | 2 | 2020 | 1041 | 0.050 |
Why?
|
| Overweight | 1 | 2013 | 2371 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2006 | 850 | 0.050 |
Why?
|
| Motion | 1 | 2006 | 798 | 0.050 |
Why?
|
| Dilatation, Pathologic | 1 | 2003 | 520 | 0.050 |
Why?
|
| Adiposity | 2 | 2023 | 1806 | 0.050 |
Why?
|
| Peroxidase | 3 | 2001 | 611 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2006 | 1081 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2005 | 2883 | 0.050 |
Why?
|
| Positron-Emission Tomography | 2 | 2016 | 6237 | 0.050 |
Why?
|
| Pandemics | 1 | 2021 | 8385 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 3778 | 0.050 |
Why?
|
| Double-Blind Method | 5 | 2013 | 12020 | 0.050 |
Why?
|
| Calibration | 1 | 2003 | 816 | 0.050 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2005 | 1159 | 0.050 |
Why?
|
| California | 2 | 2019 | 1402 | 0.050 |
Why?
|
| Pancreatic Elastase | 1 | 2001 | 136 | 0.050 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2023 | 251 | 0.050 |
Why?
|
| Societies, Scientific | 1 | 2021 | 220 | 0.050 |
Why?
|
| Consensus | 2 | 2020 | 2954 | 0.050 |
Why?
|
| Multiple Myeloma | 1 | 2018 | 5185 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2007 | 1485 | 0.050 |
Why?
|
| Intermittent Claudication | 1 | 2022 | 309 | 0.050 |
Why?
|
| Lysosomes | 3 | 1994 | 893 | 0.040 |
Why?
|
| Syndrome | 4 | 2007 | 3249 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2013 | 3530 | 0.040 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2008 | 2074 | 0.040 |
Why?
|
| Stroke | 1 | 2022 | 9975 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 3 | 2020 | 5388 | 0.040 |
Why?
|
| Esophagus | 1 | 2005 | 1019 | 0.040 |
Why?
|
| Pyrazoles | 2 | 2019 | 1970 | 0.040 |
Why?
|
| Coronary Circulation | 3 | 2015 | 1572 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 7908 | 0.040 |
Why?
|
| Oregon | 1 | 2019 | 140 | 0.040 |
Why?
|
| Boston | 4 | 2013 | 9310 | 0.040 |
Why?
|
| Linear Models | 2 | 2013 | 5952 | 0.040 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2001 | 371 | 0.040 |
Why?
|
| Free Radicals | 1 | 1999 | 237 | 0.040 |
Why?
|
| Lipoproteins, HDL | 1 | 2022 | 640 | 0.040 |
Why?
|
| Decision Making | 2 | 2015 | 3887 | 0.040 |
Why?
|
| Animals | 9 | 2019 | 168660 | 0.040 |
Why?
|
| Lactones | 1 | 2001 | 329 | 0.040 |
Why?
|
| Sulfones | 1 | 2001 | 434 | 0.040 |
Why?
|
| Aortography | 2 | 2013 | 437 | 0.040 |
Why?
|
| Spain | 1 | 2019 | 464 | 0.040 |
Why?
|
| Radiation Dosage | 2 | 2018 | 1928 | 0.040 |
Why?
|
| Lipoproteins | 1 | 2022 | 881 | 0.040 |
Why?
|
| Brachial Artery | 1 | 2019 | 369 | 0.040 |
Why?
|
| Physical Examination | 1 | 2023 | 1235 | 0.040 |
Why?
|
| Mortality | 2 | 2019 | 2862 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 1990 | 4152 | 0.040 |
Why?
|
| Anticholesteremic Agents | 1 | 2005 | 979 | 0.040 |
Why?
|
| Antibody Formation | 2 | 2000 | 1402 | 0.040 |
Why?
|
| Protein Synthesis Inhibitors | 4 | 1962 | 192 | 0.040 |
Why?
|
| Obesity | 2 | 2023 | 12744 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2005 | 2615 | 0.040 |
Why?
|
| Reference Values | 1 | 2004 | 4974 | 0.040 |
Why?
|
| Blood Bactericidal Activity | 1 | 1976 | 126 | 0.030 |
Why?
|
| Purines | 1 | 2019 | 590 | 0.030 |
Why?
|
| Antioxidants | 2 | 2006 | 1658 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2007 | 1911 | 0.030 |
Why?
|
| Singapore | 1 | 2016 | 295 | 0.030 |
Why?
|
| Tetracycline | 3 | 1961 | 214 | 0.030 |
Why?
|
| Monocytes | 1 | 2005 | 2593 | 0.030 |
Why?
|
| Electrodes | 1 | 2017 | 616 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 20827 | 0.030 |
Why?
|
| Models, Economic | 1 | 2019 | 712 | 0.030 |
Why?
|
| Phagocytosis | 2 | 2000 | 1539 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2003 | 6356 | 0.030 |
Why?
|
| Ischemia | 1 | 2023 | 1907 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2006 | 3082 | 0.030 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1994 | 131 | 0.030 |
Why?
|
| Mastectomy | 1 | 2022 | 1793 | 0.030 |
Why?
|
| Cost Savings | 1 | 2019 | 925 | 0.030 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2019 | 923 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2000 | 1608 | 0.030 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2013 | 124 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 4 | 2014 | 7270 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13691 | 0.030 |
Why?
|
| Iopamidol | 1 | 2013 | 191 | 0.030 |
Why?
|
| Patient Selection | 2 | 2017 | 4210 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2017 | 763 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2019 | 1683 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 1516 | 0.030 |
Why?
|
| Cell Communication | 1 | 2000 | 1621 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2008 | 8551 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1479 | 0.030 |
Why?
|
| Minority Groups | 1 | 2019 | 1222 | 0.030 |
Why?
|
| Necrosis | 1 | 2016 | 1642 | 0.030 |
Why?
|
| Catalase | 3 | 1976 | 221 | 0.020 |
Why?
|
| Coronary Artery Bypass | 1 | 2021 | 2288 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2001 | 1938 | 0.020 |
Why?
|
| Leukemia, Myeloid | 1 | 1994 | 707 | 0.020 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2016 | 717 | 0.020 |
Why?
|
| Intestines | 1 | 2000 | 1923 | 0.020 |
Why?
|
| Quality Control | 1 | 2013 | 841 | 0.020 |
Why?
|
| Age Distribution | 2 | 2008 | 2899 | 0.020 |
Why?
|
| Myocardial Contraction | 2 | 2006 | 1579 | 0.020 |
Why?
|
| Radiography | 1 | 2021 | 7010 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2024 | 12718 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 3794 | 0.020 |
Why?
|
| Reference Standards | 1 | 2013 | 1023 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2016 | 1444 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 1956 | 0.020 |
Why?
|
| Fibrosis | 1 | 2016 | 2030 | 0.020 |
Why?
|
| Chelating Agents | 2 | 1961 | 379 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2018 | 4221 | 0.020 |
Why?
|
| Granulocytes | 1 | 1990 | 548 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2020 | 3587 | 0.020 |
Why?
|
| Pain | 1 | 2023 | 4987 | 0.020 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2008 | 177 | 0.020 |
Why?
|
| Hospitals | 1 | 2021 | 3953 | 0.020 |
Why?
|
| Case-Control Studies | 3 | 2013 | 21733 | 0.020 |
Why?
|
| Program Development | 1 | 2013 | 1314 | 0.020 |
Why?
|
| Brain | 2 | 2006 | 26345 | 0.020 |
Why?
|
| Risk | 2 | 2012 | 9677 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 8337 | 0.020 |
Why?
|
| Electrophoresis, Paper | 1 | 1965 | 14 | 0.020 |
Why?
|
| Proteus | 1 | 1965 | 13 | 0.020 |
Why?
|
| Achromobacter | 1 | 1965 | 7 | 0.020 |
Why?
|
| Cytokines | 1 | 2001 | 7324 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2001 | 9139 | 0.020 |
Why?
|
| Cause of Death | 1 | 2016 | 3580 | 0.020 |
Why?
|
| Ornithine | 1 | 1965 | 78 | 0.020 |
Why?
|
| Age Factors | 2 | 2017 | 18355 | 0.020 |
Why?
|
| Cathepsins | 2 | 1977 | 238 | 0.020 |
Why?
|
| Electrophoresis | 1 | 1965 | 240 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 6487 | 0.020 |
Why?
|
| Carboxy-Lyases | 1 | 1965 | 90 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2016 | 25032 | 0.020 |
Why?
|
| Pseudomonas | 1 | 1965 | 117 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2018 | 63042 | 0.020 |
Why?
|
| Chickens | 3 | 1977 | 864 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2008 | 836 | 0.020 |
Why?
|
| Histidine | 1 | 1965 | 312 | 0.020 |
Why?
|
| Enterobacteriaceae | 1 | 1965 | 168 | 0.010 |
Why?
|
| Stroke Volume | 2 | 2007 | 5002 | 0.010 |
Why?
|
| Glutamates | 1 | 1965 | 397 | 0.010 |
Why?
|
| Comorbidity | 1 | 2018 | 10380 | 0.010 |
Why?
|
| Phenylalanine | 1 | 1965 | 365 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2013 | 2241 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2004 | 588 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2019 | 4370 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2018 | 3750 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2009 | 2971 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 10940 | 0.010 |
Why?
|
| Tryptophan | 1 | 1965 | 478 | 0.010 |
Why?
|
| Lipids | 1 | 2014 | 3307 | 0.010 |
Why?
|
| Myocardium | 2 | 2008 | 4775 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 1965 | 576 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 3070 | 0.010 |
Why?
|
| Heart Failure | 1 | 2006 | 10896 | 0.010 |
Why?
|
| Research Design | 1 | 2018 | 5983 | 0.010 |
Why?
|
| Physicians | 1 | 2021 | 4569 | 0.010 |
Why?
|
| Probability | 1 | 2008 | 2505 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2004 | 980 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1963 | 424 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12786 | 0.010 |
Why?
|
| Plaque, Amyloid | 1 | 2006 | 729 | 0.010 |
Why?
|
| Arginine | 1 | 1965 | 943 | 0.010 |
Why?
|
| Ciguatera Poisoning | 1 | 1961 | 1 | 0.010 |
Why?
|
| Fish Venoms | 1 | 1961 | 2 | 0.010 |
Why?
|
| Serine | 1 | 1965 | 825 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1963 | 418 | 0.010 |
Why?
|
| Microspheres | 1 | 2004 | 777 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 2006 | 748 | 0.010 |
Why?
|
| Brucella | 1 | 1961 | 10 | 0.010 |
Why?
|
| Listeria monocytogenes | 1 | 1963 | 250 | 0.010 |
Why?
|
| Foodborne Diseases | 1 | 1961 | 39 | 0.010 |
Why?
|
| Tyrosine | 1 | 1965 | 1462 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2016 | 7729 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 1963 | 424 | 0.010 |
Why?
|
| Lysine | 1 | 1965 | 1007 | 0.010 |
Why?
|
| Oxyquinoline | 1 | 1960 | 15 | 0.010 |
Why?
|
| Family Health | 1 | 2005 | 1280 | 0.010 |
Why?
|
| Tetracyclines | 1 | 1960 | 60 | 0.010 |
Why?
|
| Citrates | 1 | 1960 | 131 | 0.010 |
Why?
|
| Citric Acid | 1 | 1960 | 126 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 11360 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 2034 | 0.010 |
Why?
|
| Amino Acids | 1 | 1965 | 1733 | 0.010 |
Why?
|
| Histamine | 1 | 1961 | 507 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 4 | 1962 | 7172 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2013 | 5100 | 0.010 |
Why?
|
| Astrocytes | 1 | 2006 | 1273 | 0.010 |
Why?
|
| Quality of Life | 1 | 2019 | 12788 | 0.010 |
Why?
|
| Fishes | 1 | 1961 | 569 | 0.010 |
Why?
|
| Microglia | 1 | 2006 | 1267 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 13980 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2005 | 3912 | 0.010 |
Why?
|
| Triglycerides | 1 | 2005 | 2453 | 0.010 |
Why?
|
| Pregnancy | 1 | 2018 | 29140 | 0.010 |
Why?
|
| Geriatric Assessment | 1 | 2004 | 1372 | 0.010 |
Why?
|
| Pepstatins | 1 | 1976 | 10 | 0.010 |
Why?
|
| Acid Phosphatase | 1 | 1976 | 142 | 0.010 |
Why?
|
| Mitral Valve | 1 | 2004 | 1491 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1976 | 545 | 0.010 |
Why?
|
| DDT | 1 | 1974 | 31 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2008 | 10251 | 0.010 |
Why?
|
| Thymidine | 1 | 1994 | 310 | 0.010 |
Why?
|
| Young Adult | 1 | 2021 | 56392 | 0.010 |
Why?
|
| Bacteria | 1 | 1965 | 2112 | 0.010 |
Why?
|
| Respiratory Burst | 1 | 1994 | 114 | 0.010 |
Why?
|
| Swine | 1 | 2004 | 5909 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1994 | 821 | 0.010 |
Why?
|
| Length of Stay | 1 | 2006 | 6311 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1965 | 4216 | 0.010 |
Why?
|
| Rabbits | 2 | 1977 | 4894 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 85729 | 0.010 |
Why?
|
| Immunity | 1 | 1977 | 1013 | 0.010 |
Why?
|
| Antigens | 1 | 1974 | 1466 | 0.010 |
Why?
|
| Cell Division | 1 | 1994 | 4568 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 6311 | 0.000 |
Why?
|
| Chlortetracycline | 1 | 1962 | 5 | 0.000 |
Why?
|
| Oxytetracycline | 1 | 1962 | 9 | 0.000 |
Why?
|
| Staphylococcus | 1 | 1962 | 155 | 0.000 |
Why?
|
| Virulence | 1 | 1963 | 1328 | 0.000 |
Why?
|
| Complement Fixation Tests | 1 | 1977 | 78 | 0.000 |
Why?
|
| Hemagglutination Tests | 1 | 1977 | 75 | 0.000 |
Why?
|
| Hemagglutination | 1 | 1974 | 34 | 0.000 |
Why?
|
| Immunoglobulin G | 2 | 1977 | 4561 | 0.000 |
Why?
|
| Sheep | 1 | 1974 | 1437 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1974 | 1537 | 0.000 |
Why?
|
| Macrophages | 1 | 1977 | 5651 | 0.000 |
Why?
|